CIK 0002028614 · <br>Emerging growth company
Drugs Made In America Acquisition Corp.
Sign in to watch- Ticker
- DMAA
- Exchange
- Nasdaq
- Industry
- Blank Checks
- FY end
- Dec 31
- Entity type
- operating
- Phone
- 646-726-7074
- Business address
- 420 LEXINGTON AVENUE, SUITE 1402, NEW YORK, NY, 10170
Securities
- DMAA Ordinary Shares Nasdaq
- DMAAR Rights Nasdaq
- DMAAU Units Nasdaq
- 4 Open-market buy 10% owner bought 30,000 shares
- 4 Open-market buy CEO and Exe. Chair of Board bought 30,000 shares
- 4 Open-market buy 10% owner bought 400,000 shares
- 4 Open-market buy CEO and Executive COB bought 400,000 shares
- 4 Other acquisition Director acquired 100,000 shares (other)
- 4 Other acquisition Director acquired 100,000 shares (other)
- 4 Other acquisition Director acquired 100,000 shares (other)
- 4 Other acquisition CFO acquired 100,000 shares (other)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 1 of 1 · 14 filings